We are live on ! Find out more
SYNH

Syneos Health, Inc. Class A Common Stock

Delisted

SYNH was delisted on the 27th of September, 2023.

257 hedge funds and large institutions have $4.25B invested in Syneos Health, Inc. Class A Common Stock in 2018 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 110 increasing their positions, 76 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 30

45% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 76

7% more funds holding

Funds holding: 240257 (+17)

25% less capital invested

Capital invested by funds: $5.67B → $4.25B (-$1.42B)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
257
Holders Change
+17
Holders Change %
+7.08%
% of All Funds
5.73%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
48
Increased
110
Reduced
76
Closed
30
Calls
$853K
Puts
Net Calls
+$853K
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Skandinaviska Enskilda Banken (SEB)
76
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.22M -$204K -4,400 -5%
IM
77
Islet Management
New York
$2.95M +$3.48M +75,000 New
Citadel Advisors
78
Citadel Advisors
Florida
$2.84M -$10.9M -233,979 -76%
PP
79
Prudential plc
United Kingdom
$2.8M +$2.47M +53,151 +296%
GC
80
Guggenheim Capital
Illinois
$2.79M -$4.05M -87,154 -55%
BPIM
81
Brant Point Investment Management
New York
$2.75M -$5.54M -119,130 -63%
Man Group
82
Man Group
United Kingdom
$2.68M +$1.02M +22,049 +48%
Citigroup
83
Citigroup
New York
$2.6M +$367K +7,902 +14%
MIM
84
MetLife Investment Management
New Jersey
$2.57M -$1.67K -36 -0.1%
BMM
85
Buffington Mohr McNeal
Idaho
$2.56M -$88K -1,895 -3%
Legal & General Group
86
Legal & General Group
United Kingdom
$2.45M +$90.3K +1,943 +3%
IA
87
IndexIQ Advisors
New York
$2.33M -$225K -4,832 -8%
Macquarie Group
88
Macquarie Group
Australia
$2.29M +$70.3K +1,512 +3%
CS
89
Credit Suisse
Switzerland
$2.26M +$113K +2,425 +4%
WB
90
WesBanco Bank
West Virginia
$2.17M +$563K +12,127 +28%
MOACM
91
Mutual of America Capital Management
New York
$2.13M +$107K +2,298 +4%
BA
92
Boston Advisors
Massachusetts
$2.12M +$2.5M +53,884 New
Comerica Bank
93
Comerica Bank
Texas
$2.03M +$34.2K +737 +2%
NEI
94
Northwest & Ethical Investments
Ontario, Canada
$1.98M +$2.34M +50,422 New
Canada Life
95
Canada Life
Manitoba, Canada
$1.94M +$886K +19,072 +58%
GAM
96
Gotham Asset Management
New York
$1.91M +$1.73M +37,259 +328%
CAM
97
ClariVest Asset Management
California
$1.87M -$32.5K -700 -1%
ProShare Advisors
98
ProShare Advisors
Maryland
$1.86M -$435K -9,352 -16%
Envestnet Asset Management
99
Envestnet Asset Management
Illinois
$1.85M +$2.19M +47,073 New
CEP
100
Chicago Equity Partners
Illinois
$1.83M +$677K +14,575 +46%

SYNH Hedge Fund Activity: Q4 2018 in Review

257 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q4 2018, worth a combined $4.25B — down 25% from $5.67B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new SYNH positions and 30 closed out — a net gain of 18 holders — while 110 added to existing stakes and 76 trimmed.

The largest buyer was Glenmede Trust, opening a new position worth an estimated $33.2M. The largest seller was Element Capital Management, cutting an estimated $29.7M.

  • 257 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q4 2018, up from 240 in Q3 2018.
  • Funds reported $4.25B of Syneos Health, Inc. Class A Common Stock stock for Q4 2018, down 25% quarter-over-quarter.
  • 48 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q4 2018 and 30 closed out, a net change of +18 holders.
  • The largest Syneos Health, Inc. Class A Common Stock buyer in Q4 2018 was Glenmede Trust, an estimated $33.2M added.
  • The largest Syneos Health, Inc. Class A Common Stock seller in Q4 2018 was Element Capital Management, an estimated $29.7M sold.

Based on aggregated 13F filings for Q4 2018.